IAM1363-01: A Phase 1/1b Study of a Selective and Brain-Penetrant HER2 Inhibitor for HER2-Driven Solid Tumors
Publications
This is some text inside of a div block.
June 1, 2024
Publication
June 1, 2024
IAM1363-01: A Phase 1/1b Study of a Selective and Brain-Penetrant HER2 Inhibitor for HER2-Driven Solid Tumors
Let's work together
Leverage the Iambic discovery process for your program. Reach out to us at partnerships@iambic.ai.
Contact us
Better technology for better medicines
GET IN TOUCH
contact@iambic.ai
(619) 330-5499
Copyright © 2026 Iambic Therapeutics, Inc. All Rights Reserved.